Octapharma AG Releases 2011 Annual Report
4/3/2012 10:19:14 AM
LACHEN, Switzerland--(BUSINESS WIRE)--2011 has been a successful transitional year for the Octapharma Group. Since octagam® 5% and 10% re-entered all important markets profitability experienced a month-by-month continuous improvement. Re-entry combined with the strong demand for our Haematology and Intensive Care products has led to the successful turnaround of the Octapharma Group in 2011.